Anthony Petrone
Stock Analyst at Mizuho Securities
(4.09)
# 1,630
Out of 4,371 analysts
626
Total ratings
48.4%
Success rate
5.3%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintained: Buy | $100 → $85 | $62.02 | +37.05% | 39 | Jun 3, 2026 | |
| MDT Medtronic | Maintained: Buy | $120 → $100 | $81.93 | +22.06% | 28 | Jun 3, 2026 | |
| MMED MiniMed Group | Maintained: Buy | $21 | $14.06 | +49.36% | 3 | Jun 3, 2026 | |
| LNTH Lantheus Holdings | Maintained: Buy | $100 → $115 | $102.82 | +11.85% | 35 | May 27, 2026 | |
| STAA STAAR Surgical Company | Maintained: Hold | $22 → $27 | $29.86 | -9.58% | 31 | May 14, 2026 | |
| TFX Teleflex | Maintained: Hold | $135 → $140 | $132.11 | +5.97% | 21 | May 8, 2026 | |
| TNDM Tandem Diabetes Care | Maintained: Hold | $22 → $24 | $19.45 | +23.39% | 7 | May 8, 2026 | |
| MNKD MannKind | Maintained: Buy | $8 → $7 | $3.52 | +98.86% | 4 | May 7, 2026 | |
| ADMA ADMA Biologics | Maintained: Buy | $24 → $20 | $7.98 | +150.63% | 33 | May 7, 2026 | |
| LIVN LivaNova | Maintained: Buy | $85 → $90 | $73.72 | +22.08% | 27 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 75.12 → CHF 67.21 | $52.08 | +29.05% | 23 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $5 | $3.41 | +46.63% | 7 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $55 | $42.19 | +30.36% | 19 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $255 → $235 | $194.32 | +20.93% | 30 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $75 | $72.59 | +3.32% | 10 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $8 | $3.78 | +111.64% | 20 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 → $160 | $121.69 | +31.48% | 26 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $80 | $63.81 | +25.37% | 20 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $55 | $42.39 | +29.75% | 3 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 → $100 | $87.45 | +14.35% | 29 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $48.85 | - | 23 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $125 → $115 | $90.78 | +26.68% | 20 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 → $70 | $69.85 | +0.21% | 68 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $525 | $418.82 | +25.35% | 17 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $7.01 | +185.31% | 5 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $26.98 | +11.21% | 5 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $76.49 | +30.74% | 30 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $52.26 | +91.35% | 1 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $133.06 | -51.15% | 1 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $175 | $86.69 | n/a | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $70 | $93.56 | n/a | 1 | Sep 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $0.881 | n/a | 3 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 | $60.34 | n/a | 7 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $86 | $17.56 | n/a | 1 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $0.488 | n/a | 1 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $18 | $10.46 | n/a | 8 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $0.0001 | n/a | 5 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $0.3655 | n/a | 7 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 → $95 | - | n/a | 4 | Mar 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 | $212.61 | n/a | 1 | Aug 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $97 | $10.67 | n/a | 1 | Aug 2, 2016 |
The Cooper Companies
Jun 3, 2026
Maintained: Buy
Price Target: $100 → $85
Current: $62.02
Upside: +37.05%
Medtronic
Jun 3, 2026
Maintained: Buy
Price Target: $120 → $100
Current: $81.93
Upside: +22.06%
MiniMed Group
Jun 3, 2026
Maintained: Buy
Price Target: $21
Current: $14.06
Upside: +49.36%
Lantheus Holdings
May 27, 2026
Maintained: Buy
Price Target: $100 → $115
Current: $102.82
Upside: +11.85%
STAAR Surgical Company
May 14, 2026
Maintained: Hold
Price Target: $22 → $27
Current: $29.86
Upside: -9.58%
Teleflex
May 8, 2026
Maintained: Hold
Price Target: $135 → $140
Current: $132.11
Upside: +5.97%
Tandem Diabetes Care
May 8, 2026
Maintained: Hold
Price Target: $22 → $24
Current: $19.45
Upside: +23.39%
MannKind
May 7, 2026
Maintained: Buy
Price Target: $8 → $7
Current: $3.52
Upside: +98.86%
ADMA Biologics
May 7, 2026
Maintained: Buy
Price Target: $24 → $20
Current: $7.98
Upside: +150.63%
LivaNova
May 7, 2026
Maintained: Buy
Price Target: $85 → $90
Current: $73.72
Upside: +22.08%
May 7, 2026
Maintained: Buy
Price Target: CHF 75.12 → CHF 67.21
Current: $52.08
Upside: +29.05%
May 6, 2026
Maintained: Hold
Price Target: $12 → $5
Current: $3.41
Upside: +46.63%
May 5, 2026
Maintained: Buy
Price Target: $70 → $55
Current: $42.19
Upside: +30.36%
May 4, 2026
Maintained: Buy
Price Target: $255 → $235
Current: $194.32
Upside: +20.93%
May 1, 2026
Maintained: Buy
Price Target: $90 → $75
Current: $72.59
Upside: +3.32%
Apr 30, 2026
Maintained: Buy
Price Target: $10 → $8
Current: $3.78
Upside: +111.64%
Apr 30, 2026
Maintained: Buy
Price Target: $130 → $160
Current: $121.69
Upside: +31.48%
Apr 30, 2026
Maintained: Buy
Price Target: $90 → $80
Current: $63.81
Upside: +25.37%
Apr 29, 2026
Maintained: Buy
Price Target: $40 → $55
Current: $42.39
Upside: +29.75%
Apr 24, 2026
Maintained: Buy
Price Target: $95 → $100
Current: $87.45
Upside: +14.35%
Apr 21, 2026
Maintained: Buy
Price Target: n/a
Current: $48.85
Upside: -
Apr 20, 2026
Maintained: Hold
Price Target: $125 → $115
Current: $90.78
Upside: +26.68%
Apr 13, 2026
Rated: Buy
Price Target: $80 → $70
Current: $69.85
Upside: +0.21%
Apr 13, 2026
Rated: Hold
Price Target: $525
Current: $418.82
Upside: +25.35%
Apr 13, 2026
Maintained: Buy
Price Target: $20
Current: $7.01
Upside: +185.31%
Apr 13, 2026
Maintained: Buy
Price Target: $30
Current: $26.98
Upside: +11.21%
Apr 13, 2026
Maintained: Buy
Price Target: $100
Current: $76.49
Upside: +30.74%
Apr 13, 2026
Maintained: Buy
Price Target: $100
Current: $52.26
Upside: +91.35%
Jun 13, 2025
Maintained: Buy
Price Target: $65
Current: $133.06
Upside: -51.15%
Nov 5, 2021
Maintained: Buy
Price Target: $175
Current: $86.69
Upside: n/a
Sep 16, 2021
Rated: Buy
Price Target: $70
Current: $93.56
Upside: n/a
Aug 11, 2021
Rated: Buy
Price Target: $20
Current: $0.881
Upside: n/a
Aug 10, 2021
Rated: Buy
Price Target: $45
Current: $60.34
Upside: n/a
May 20, 2021
Rated: Buy
Price Target: $86
Current: $17.56
Upside: n/a
Sep 17, 2020
Initiated Coverage: Buy
Price Target: $15
Current: $0.488
Upside: n/a
Aug 13, 2020
Maintained: Hold
Price Target: $25 → $18
Current: $10.46
Upside: n/a
Dec 3, 2019
Maintained: Buy
Price Target: $7
Current: $0.0001
Upside: n/a
Aug 17, 2018
Reiterated: Buy
Price Target: $7 → $6
Current: $0.3655
Upside: n/a
Mar 5, 2018
Reiterated: Hold
Price Target: $80 → $95
Current: -
Upside: n/a
Aug 25, 2017
Maintained: Buy
Price Target: $93
Current: $212.61
Upside: n/a
Aug 2, 2016
Reiterated: Hold
Price Target: $97
Current: $10.67
Upside: n/a